No results.

GLAUCOMA 360

Presented annually by Glaucoma Research Foundation, Glaucoma 360 is a series of annual events uniting research, industry, and philanthropy with one mission — to find a cure for glaucoma. The 12th Annual Glaucoma 360 will in San Francisco February 2 - 4, 2023. More information: glaucoma360.org

  1. Keynote Lecture: Ranya Habash, MD —The Future of Eye Care: Science Fiction to Science Fact

    2022 New Horizons Forum Opening Keynote Address - The Drs. Henry and Frederick Sutro Memorial Lecture by Ranya Habash, MD (CEO, LifeLong Vision; Microsoft AI for Health; FDA Digital Health Network of Experts; Chief Medical Officer, Everbridge; Medical Director, Technology Innovation; Assistant Professor of Ophthalmology, Bascom Palmer Eye Institute)

  2. Welcome and Opening Remarks - New Horizons Forum 2022

    Adrienne L. Graves, PhD and Andrew G. Iwach, MD
    Co-Founders and Co-Chairs, Glaucoma 360
    The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

  3. The Pressure's On: An Inside Look at the Glaucoma Treatment Market

    The Pressure's On: An Inside Look at the Glaucoma Treatment Market - Kristin H. Ingenito, MBA, Vice President, Director of Ophthalmics, Market Scope.

    The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

  4. Diagnostics: Getting Smarter, Smaller and Virtually Leaving Your Practice

    Diagnostics: Getting Smarter, Smaller and Virtually Leaving Your Practice -
    Moderators:
    Sean Ianchulev, MD, MPH
    Professor of Ophthalmology, Director of Innovation and Technology, New York
    Eye and Ear of Mount Sinai, Icahn School of Medicine; CEO, Eyenovia, Inc.
    Joel S. Schuman, MD, FACS
    Elaine Langone Professor of Ophthalmology & Vice Chair for Ophthalmology
    Research, Professor of Neuroscience and Physiology, NYU Langone Health, NYU
    Grossman School of Medicine; Professor of Biomedical Engineering and Electrical
    & Computer Engineering, NYU Tandon School of Engineering; Professor of Neural
    Science, NYU College of Arts and Sciences
    Speakers:
    AEYE Health, Zack Dvey-Aharon, PhD, CEO and Co-Founder
    Eyenuk Inc., Kaushal Solanki, PhD, CEO and Founder
    Hao F. Zhang, PhD, Professor of Biomedical Engineering, Northwestern University
    Heru, Mary Durbin, PhD, Chief Scientific Officer
    FDA, Malvina Eydelman, MD, Director of the Office of Health Technology,
    Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices
    Ophthalmic Sciences, Ariel Weinstein, MSc, EMT-P, Chief Executive Officer
    Audience Q&A

    The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

  5. Remote Patient Management: Are We Ready?

    Remote Patient Management: Are We Ready?
    Moderators:
    Lama Al-Aswad, MD, MPH
    Vice Chair of Innovations, Langone Department of Ophthalmology; Professor of
    Ophthalmology and Director of Tele-Ophthalmology, Artificial Intelligence and
    Innovations, Director of the Ophthalmology Innovation Fellowship, NYU Langone
    Eye Center
    Oluwatosin “Tosin” Smith, MD
    Attending Physician and Surgeon, Glaucoma Associates of Texas; Associate
    Professor of Ophthalmology, Department of Ophthalmology, University of Texas
    Southwestern Medical School.
    Panelists:
    Malvina Eydelman, MD, Director of the Office of Health Technology, Ophthalmic,
    Anesthesia, Respiratory, ENT and Dental Devices, FDA
    Ronald L. Fellman, MD, Glaucoma Specialist, Ophthalmologist, Glaucoma
    Associates of Texas and The Cure Glaucoma Foundation
    Jonathan S. Myers, MD, Chief, Glaucoma Service, Wills Eye Hospital; Professor,
    Sidney Kimmel Medical College, Thomas Jefferson University
    Speakers:
    Aenor J. Sawyer, MD, MS, Director of UCSF Skeletal Health Service; Director of
    UC Space Health, Department of Orthopaedic Surgery, UCSF; Co-Director of UCSF
    Center for Advanced 3D + Technologies
    Seanna Grob, MD, MS, Assistant Professor, Depart of Ophthalmology, University
    of California, San Francisco
    Implandata Ophthalmic Products, Max Ostermeier, CEO & Founder
    Microsoft, Pam Nesbitt, MSc, Global Healthcare Lead, CSE
    PeriVision, Patrick Kessel, Chief Executive Officer and Co-founder
    Twenty Twenty Therapeutics, Christian Gutierrez, PhD, Head of Digital
    Therapeutics and Director of Business Development
    Audience Q&A

    The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

  6. Expanding Beyond the Horizon with Devices in Glaucoma

    Expanding Beyond the Horizon with Devices in Glaucoma -
    Moderators:
    Shan Lin, MD, Ophthalmologist, Glaucoma Center of San Francisco
    Barbara Wirostko, MD, FARVO
    Chief Medical Officer and Co-Founder, Qlaris Bio Inc.; Adjunct Professor,
    Department of Ophthalmology, Moran Eye Center and Department of Biomedical
    Engineering, University of Utah
    Presenting Companies:
    Ace Vision, AnnMarie Hipsley, DPT, PhD, Founder and CEO
    Iridex, David Bruce, President and Chief Executive Officer
    MicroOptx, Chris Pulling, Chief Executive Officer
    OcuFLOW, Theresa Kramer, MD, MBA, President, Founder, CEO and CMO
    Robert Weinreb, MD, Chair & Distinguished Professor of Ophthalmology,
    Director of the Shiley Eye Institute, Distinguished Professor of Bioengineering,
    University of California, San Diego
    ViaLase, Tibor Juhasz, Chief Executive Officer
    W. L. Gore & Associates, Kevin Savory, PhD, Product Specialist
    Audience Q&A

    The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

Powered by Vimeo Pro